ag-1296 has been researched along with Mast Cell Activation Disease in 1 studies
6,7-dimethoxy-3-phenylquinoxaline: ATP-competitive inhibitor of receptor kinase
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Letard, S | 1 |
| Yang, Y | 1 |
| Hanssens, K | 1 |
| Palmérini, F | 1 |
| Leventhal, PS | 1 |
| Guéry, S | 1 |
| Moussy, A | 1 |
| Kinet, JP | 1 |
| Hermine, O | 1 |
| Dubreuil, P | 1 |
1 other study available for ag-1296 and Mast Cell Activation Disease
| Article | Year |
|---|---|
Gain-of-function mutations in the extracellular domain of KIT are common in canine mast cell tumors.
Topics: Animals; Cell Line; Cell Proliferation; Dogs; Extracellular Space; Female; Flow Cytometry; Intercell | 2008 |